Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

These findings suggest potential advancements in developing new treatments to improve posttreatment immune responses and address resistance challenges.

Authors

Institutions

Publication Details

Journal
British Journal of Cancer
Published
2025-07-16
DOI
https://doi.org/10.1038/s41416-025-03088-0
Citations
6
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
6.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Junko Zenkoh, Shun‐Ichiro Kageyama, Shunsuke A. Sakai, Junichi Soh et al.
6 citations
British Journal of Cancer
Cancer Immunotherapy and Biomarkers
6.27
article

Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Junko Zenkoh, Shun‐Ichiro Kageyama, Shunsuke A. Sakai, Junichi Soh, Katsuya Tsuchihara, Yuka Nakamura, Keiju Aokage, Hidenari Hirata, Kotaro Nomura, Hidekazu Oyoshi, Masaki Nakamura, Masahiro Tsuboi, Genichiro Ishii, Takeshi Kuwata, Ayako Suzuki, Atsushi Motegi, Akira Hamada, Yutaka Suzuki, Tetsuro Taki, Hidehiro Hojo, Tetsuo Akimoto, Tetsuya Mitsudomi, Motohiro Kojima, Riu Yamashita
article en
6 citations

Abstract

These findings suggest potential advancements in developing new treatments to improve posttreatment immune responses and address resistance challenges.

British Journal of CancerVol. 133(6)
Ube Frontier University (JP), Kyoto Prefectural University of Medicine (JP), Chiba Cancer Center (JP), National Cancer Center Hospital East (JP), The University of Tokyo (JP), Kindai University (JP)
Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, Japan Science and Technology Agency
Openalex Percentile: Top 3%
Cancer Immunotherapy and Biomarkers
6.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.